How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,563 results for

Preoperative Guidelines for Medications Prior to Surgery

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Dual Antiplatelet Therapy in Patients With Coronary Artery Disease (Focused Update)

Dual Antiplatelet Therapy in Patients With Coronary Artery Disease (Focused Update) ACC/AHA FOCUSED UPDATE 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (...) SYNDROME (NSTE-ACS AND STEMI) 1099 7.1. Duration of DAPT in Patients With ACS Treated With Medical Therapy Alone (Without Revascularization or Fibrinolytic Therapy): Recommendations 1099 7.2. Duration of DAPT in Patients With STEMI Treated With Fibrinolytic Therapy: Recommendations 1099 This article has been copublished in Circulation. It has been reprinted by the Journal of Thoracic and Cardiovascular Surgery. Copies: This document is available on the World Wide Web sites of the American College

2016 American College of Cardiology

142. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications Full Text available with Trip Pro

, mural, infection, diagnosis, bacteremia, case definition, epidemiology, risks, demographics, injection drug use, echocardiography, microbiology, culture-negative, therapy, antibiotic, antifungal, antimicrobial, antimicrobial resistance, adverse drug effects, drug monitoring, outcome, meta-analysis, complications, abscess, heart failure, embolic events, stroke, conduction abnormalities, survival, pathogens, organisms, treatment, surgery, indications, valve replacement, valve repair, ambulatory care (...) for surgery based on vegetation characterizations. *Surgery may be required because of risk of embolization. †Surgery may be required because of heart failure or failure of medical therapy. ‡Echocardiography should not be the primary modality used to detect or monitor heart block. Recommendation TTE should be performed in all cases of suspected IE ( Class I; Level of Evidence B ). Repeat Echocardiography If the initial TTE images are negative and the diagnosis of IE is still being considered, then TEE

2016 Infectious Diseases Society of America

143. External Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer

stage T2b tumor, PSA 10–20 ng/mL, or Gleason score 7; and high risk, for clinical stage T2c tumor, PSA >20 ng/mL, or Gleason score =8 [9]. The NCCN risk-grouping system is similar to the D’Amico guidelines, with the exceptions of including T2c tumors in the intermediate-risk group and T3a tumors in the high-risk group [6]. Radiation Therapy Fractionation Definitions This article relates mostly to men treated with dose-escalated conventionally fractionated EBRT (a single 1.8- to 2.0-Gy fraction (...) ) guidelines include recommendations for CTV definition according to risk group for prostate EBRT [32]. The EORTC guidelines recommend that the CTV include a 5-mm expansion of the prostate to address EPE for patients with intermediate- and high-risk tumors and that the proximal 1 cm or 2 cm of the SVs be included for patients with intermediate- and high-risk tumors, respectively [32]. The most recent Radiation Therapy Oncology Group ® (RTOG) protocol for high-risk prostate cancer (0924) recommends

2016 American College of Radiology

144. Peri-Operative Management of Anticoagulation and Antiplatelet Therapy

on DOACs prior to emergency surgery (2D) ? Tranexamic acid is likely to reduce bleeding in patient who have a residual anticoagulant effect (1C). ? Drugs and colloids that impair the haemostatic mechanism should be avoided in the peri-surgical management of patients receiving DOACs (2D) ? Idarucizumab should be used to reverse dabigatran therapy prior to emergency invasive procedures and surgery where the bleeding risk is considered significant (1C) 17 ? Andexanet, when available, should be used (...) of Regional Anesthesia and Pain Medicine evidence-based guidelines (Third Edition). Regional Anesthesia and Pain Medicine, 35, 64-101. Jamula, E., Anderson, J. & Douketis, J.D. (2009) Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thrombosis Research, 124, 292-299. Kaatz, S., Douketis, J.D., White, R.H. & Zhou, H. (2011) Can the CHADS2 score predict postoperative stroke risk in patients with chronic atrial fibrillation who are having elective non

2016 British Committee for Standards in Haematology

145. Guidelines on the Prevention of Postoperative Vomiting in Children

Courtman Neil Morton Scott Jacobson Liam Brennan Per-Arne Lönnqvist Jackie Pope 3 Contents Page No. Key to evidence statements and grades of recommendation 4 Introduction 5 Remit of the guideline Glossary 7 1. Identifying children at high risk of postoperative vomiting (POV) 8 A. Patient factors Age, history of POV, motion sickness, gender, preoperative anxiety, smoking 8 B. Surgical Factors Duration of surgery, type of surgery 10 C. Anaesthetic Factors Nitrous oxide, volatile agents, peri-operative (...) surgery with resulting increased health care costs 5,6 . Importantly, no research has focused on the children’s perspective of POV, and whether they perceive this symptom with the same distress and loathing as adults 7 . Identifying children at high risk of POV is beneficial as prophylactic antiemetic therapy can then be targeted at this group. Indiscriminate prophylaxis is probably unnecessary as it is financially costly and may result in excessive adverse drug reactions 8 . Research

2017 Association of Paediatric Anaesthetists of Great Britain and Ireland

146. Clinical Practice Guideline on the Management of Osteoarthritis of the Hip

Some drugs or medical devices referenced or described in this Clinical Practice Guideline may not have been cleared by the Food and Drug Administration (FDA) or may have been cleared for a specific use only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. Copyright All rights reserved. No part of this Clinical Practice Guideline may be reproduced, stored in a retrieval system (...) , or transmitted, in any form, or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the AAOS. If you wish to request permission please contact the AAOS Evidence-Based Medicine Unit at ebm@aaos.org. Published 3/13/17 by the American Academy of Orthopaedic Surgeons 9400 West Higgins Rd. Rosemont, IL 60018 First Edition Copyright 3/13/17 by the American Academy of Orthopaedic Surgeons 2 To View All AAOS Evidence-Based Guidelines and Appropriate Use

2017 American Academy of Orthopaedic Surgeons

147. The Diagnosis and Acute Management of Childhood Stroke, Clinical Guideline

Methylenetetrahydrofolate reductase NHMRC National Health and Medical Research Council PAI-1 Plasminogen Activator Inhibitor-1 PedNIHSS Pediatric National Institute of Health Stroke Severity Scale PFO Patent foreman ovale PPSC Primary Paediatric Stroke Centre PTT Partial Thromboplastin Time ROSIER Recognition of Stroke in the Emergency Room SAA Serum amyloid A SBP Systolic Blood Pressure SIGN Scottish Intercollegiate Guidelines Network SWI Susceptibility Weighted Imaging TIMPs Tissue Inhibitors of Matrix (...) substantial implications for clinical treatment, concerning ongoing radiological surveillance, and choice of medical or surgical therapies for specific arteriopathy subtypes. While the level of evidence is low, studies are consistent in demonstrating an association between arteriopathies and initial stroke event, and risk of recurrence of childhood arterial ischaemic stroke. Table 14. Recommendations for investigating arteriopathies Strong Recommendation Vascular imaging (MR or CT angiography

2017 Stroke Foundation - Australia

148. Prosthetic and Amputee Rehabilitation - Standards and Guidelines (3rd Edition)

Hanspal & Dr Imad Sedki Published by the British Society of Rehabilitation Medicine 2018 (registered charity number 293196) The British Society of Rehabilitation Medicine (BSRM) is the society which represents the specialty of Rehabilitation Medicine. It promotes an understanding of the specialty through education and the development of clinical guidelines and standards. Membership is open to all registered medical practitioners interested and concerned with its objectives. Further information (...) Prosthetic and Amputee Rehabilitation - Standards and Guidelines (3rd Edition) Amputee and Prosthetic Rehabilitation – Standards and Guidelines (3 rd Edition) A Report of the Working Party of the British Society of Rehabilitation Medicine Published by the British Society of Rehabilitation Medicine in 2018 Amputee and Prosthetic Rehabilitation – Standards and Guidelines (3 rd Edition) A Report of the Working Party of the British Society of Rehabilitation Medicine Co-Chairs: Professor Rajiv

2018 British Society of Rehabilitation Medicine

149. BTS guideline for oxygen use in adults in healthcare and emergency settings.

in the original guideline document) The use of Entonox gas mixture for analgesia should be avoided if possible in patients at risk of hypercapnic respiratory failure ( grade D ). CPAP and Humidified High-flow Nasal Oxygen Use of CPAP in the Perioperative Period and for Pulmonary Oedema (see section 8.19 in the original guideline document) Patients with diagnosed sleep-disordered breathing established on CPAP undergoing surgery should bring their machines with them and use them in the preoperative (...) is used for patients with known COPD, its use should be limited to 6 min. This will deliver most of the nebulised drug dose but limit the risk of hypercapnic respiratory failure (section 10.4 in the original guideline document). Ambulance services are encouraged to explore the feasibility of introducing battery-powered, air-driven nebulisers or portable ultrasonic nebulisers. Prescribing Oxygen Therapy (see section 11 in the original guideline document) Every healthcare facility should have a standard

2017 National Guideline Clearinghouse (partial archive)

150. 4th ESO?ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

, European Medicines Agency; EORTC, European Organisation for Research and Treatment of Cancer; ESMO-MCBS, European Society for Medical Oncology Magnitude of Clinical Bene?t Scale; FACT, Functional Assessment of Cancer Therapy; FDA, Food and Drug Administration; GoR, grade of recommendation; LoE, available level of evidence; PRO, patient- reported outcome; PROM, patient-reported outcome measure; QoL, qual- ity of life. Special article Annals of Oncology 1638 | Cardoso et al. Volume 29 | Issue 8 (...) , grades of recommendation (GoRs), percentages of consensus reached at the Conference and supporting references. In addition, the ESMO Magnitude of Clinical Bene?t Scale (ESMO-MCBS) was applied to new European Medicines Agency (EMA)-approved drugs [9], and ESMO-MCBS scores for new therapies/indications are included. ESMO-MCBS version 1.1 (v1.1) [9] was used to calculate scores for new therapies/ indications approved by the EMA since 1 January 2016. Methodology Before the ABC 4 Conference, a set

2018 European Society for Medical Oncology

151. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Full Text available with Trip Pro

Microsite Search Term Close search filter search input Abstract The most recent version of the European Society for Medical Oncology (ESMO) consensus guidelines for the treatment of patients with metastatic colorectal cancer (mCRC) was published in 2016, identifying both a more strategic approach to the administration of the available systemic therapy choices, and a greater emphasis on the use of ablative techniques, including surgery. At the 2016 ESMO Asia Meeting, in December 2016, it was decided (...) , University of Ulsan College of Medicine, Seoul, Korea; Search for other works by this author on: F Ismail Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia; Search for other works by this author on: I B Tan Division of Medical Oncology, National Cancer Centre, Singapore, Singapore; Search for other works by this author on: K -H Yeh Department of Oncology, National Taiwan University Hospital, and Cancer Research Center, National Taiwan University

2018 European Society for Medical Oncology

152. Hepatocellular Carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Guidelines Committee * 1 Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany; 2 Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain; 3 Department of Medicine, Royal Marsden Hospital, Surrey, UK; 4 Dipartimento di Oncologia, A. O. G. Rummo, Benevento, Italy; 5 Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA; 6 Barcelona-Cli (...) , Asklepios Tumorzentrum Hamburg, Hamburg, Germany; 18 Faculty of Medicine, Universita ` della Campania L. Vanvitelli Naples, Caserta, Italy *Correspondence to: ESMO Guidelines Committee, ESMO Head Of?ce, Via Ginevra 4, 6900 Lugano, Switzerland. E-mail: clinicalguidelines@esmo.org † Approved by the ESMO Guidelines Committee: August 2018. Incidence and epidemiology The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last 20 years and is expected to increase until 2030 in some

2018 European Society for Medical Oncology

153. Bone sarcomas: ESMO?PaedCan?EURACAN: Clinical Practice Guidelines for diagnosis, treatment and follow-up

for surgery [IV, B]. Some groups also consider radiofrequency ablation [52, 53] and stereo- tactic RT [54] to be potential alternative local treatment options for primary lung or bone metastases [52–54]. The role of second-line chemotherapy for recurrent OS is much less well de?ned. Treatment choice may take into account the prior disease-free interval, and often includes ifosfamide or cyclophosphamide, possibly in association with etoposide and/or carboplatin [III, B]; other active drugs and combinations (...) and clinical bene?t are commonly witnessed so that its use should be considered [IV, B]. RT may have a role in palliation. In general, despite second- line treatment, the prognosis of recurrent disease has remained poor, with a long-term post-relapse survival rate of 15 years. A poor histological response to preoperative ChT and incomplete or no surgery for local therapy are further adverse prognostic factors [71–75]. The molecular structure of the EWSR1 fusion tran- scripts has not been shown

2018 European Society for Medical Oncology

154. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

. Choice of Initial Medication e46 8.2. Achieving BP Control in Individual Patients e47 8.3. Follow-Up of BP During Antihypertensive Drug Therapy e48 8.3.1. Follow-Up After Initiating Antihypertensive Drug Therapy e48 8.3.2. Monitoring Strategies to Improve Control of BP in Patients on Drug Therapy for High BP e48 9. Hypertension in Patients With Comorbidities e48 9.1. Stable Ischemic Heart Disease e49 9.2. Heart Failure e50 9.2.1. Heart Failure With Reduced Ejection Fraction e50 9.2.2. Heart Failure (...) Management and Therapy The term guideline-directed management and therapy (GDMT) encompasses clinical evaluation, diagnostic testing, and pharmacological and procedural treatments. For these and all recommended drug treatment regimens, the reader should confirm the dosage by reviewing product insert material and evaluate the treatment regimen for contraindications and interactions. The recommendations are limited to drugs, devices, and treatments approved for clinical use in the United States. Class

2017 American Heart Association

155. High Blood Pressure in Adults: Guideline For the Prevention, Detection, Evaluation and Management

8.1.3. Follow-Up After Initial BP Evaluation .. e163 8.1.4. General Principles of Drug Therapy .. .. e164 8.1.5. BP Goal for Patients With Hypertension . e167 8.1.6. Choice of Initial Medication . .. e168 8.2. Achieving BP Control in Individual Patients .. e169 8.3. Follow-Up of BP During Antihypertensive Drug Therapy ... e170 8.3.1. Follow-Up After Initiating Antihypertensive Drug Therapy .. e170 8.3.2. Monitoring Strategies to Improve Control of BP in Patients on Drug Therapy for High BP (...) . Performance Measures .. e205 12.4.2. Quality Improvement Strategies ... .. e205 12.5. Financial Incentives . e206 13.THE PLAN OF CARE FOR HYPERTENSION . e207 13.1. Health Literacy e207 13.2. Access to Health Insurance and Medication Assistance Plans e207 13.3. Social and Community Services e207 JACC VOL. 71, NO. 19, 2018 Whelton et al. MAY 15, 2018:e127–248 2017 High Blood Pressure Clinical Practice Guideline e12914.SUMMARY OF BP THRESHOLDS AND GOALS FOR PHARMACOLOGICAL THERAPY .. e208 15.EVIDENCE GAPS

2017 American College of Cardiology

156. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

following preoperative treatments if adequate margins cannot be achieved, or if surgery is mutilating. In the latter case, the use of multimodal therapy with less radical surgery is optional and requires shared decision making with the patient in cases of uncer- tainty. Plastic repairs and vascular grafting should be used as needed, and the patient should be properly referred as necessary. RT will follow marginal or R1–R2 excisions, if these cannot be rescued through re-excision, tailoring the decision (...) is gemcitabine, possibly in combination with doce- taxel [V, B] [31]. Doxorubicin plus dacarbazine is an option for multi-agent, ?rst-line ChT of LMS, in which the activity of ifosfamide is far less convincing in available retrospective evidence, or of solitary ?brous tumours [V, B] [32]. Imatinib is standard medical therapy for those rare patients with dermato?brosarcoma protuberans who are not amenable to non-mutilating surgery or with metastases deserving medical therapy [III, A] [33]. Similarly, imatinib

2018 European Society for Medical Oncology

157. Non-Epithelial Ovarian Cancer: ESMO Clinical Practice Guidelines

of the Infectious Diseases Society of America [58]. Clinical Practice Guidelines Annals of Oncology iv14 | Ray-Coquard et al. Volume 29 | Supplement 4 | October 2018 Downloaded from https://academic.oup.com/annonc/article-abstract/29/Supplement_4/iv1/4983953 by guest on 16 April 2019A combination of a cisplatin and etoposide-based therapy is generally considered most appropriate [III, B] [22, 36]. As reported in early stage, HDCT for patients who underwent a CR (after surgery and/or ChT) with ASCT rescue has (...) . Optional BEP, bleomycin/etoposide/cisplatin; GCT, germ cell tumour. Clinical Practice Guidelines Annals of Oncology iv6 | Ray-Coquard et al. Volume 29 | Supplement 4 | October 2018 Downloaded from https://academic.oup.com/annonc/article-abstract/29/Supplement_4/iv1/4983953 by guest on 16 April 2019Active surveillance* [GoR C] Yolk sac tumour Stage IA-IB Stage IC-IV Fertility-sparing surgery Staging [III, A] Debulking/Staging [III, A] or Fertility-sparing surgery Staging [IV, B] Standard follow-up BEP x

2018 European Society for Medical Oncology

158. Valvular Heart Disease (Focused Update): Guidelines For the Management of Patients With

From 2014 VHD Guideline) AVR is indicated for survival bene?t, improvement in symptoms, and improvement in left ventricular (LV) systolic function in patients with severe symptomatic AS (Section 3.2.3 in the 2014 VHD guideline) (42–48). Given the magnitude of the difference in outcomes between those undergoing AVR and those who refuse AVR in historical series, an RCT of AVR versus medical therapy would not be appropriate in patients with a low-to- intermediate surgical risk (Section 2.5 in the 2014 (...) DataSupplements 5 and 9 (Updated From 2014 VHD Guideline) TAVR was compared with standard therapy in a prospective RCT of patients with severe symptomatic AS who were deemed inoperable (53,58,60). The rate of all-cause death at 2 years was lower with TAVR (43.3%) (HR: 0.58; 95% CI: 0.36 to 0.92; p¼0.02) than with standard medical therapy (68%)(53,58,60).Standardtherapyincludedpercutaneousaorticballoondilationin84%.TherewasareductioninrepeathospitalizationwithTAVR (55% versus 72.5%; p 1 year after intervention

2017 American College of Cardiology

159. Ankle and Foot Surgical Guideline

medicine, occupational medicine, orthopedic surgery, and podiatry. The guideline recommendations are based on the weight of the best available clinical and scientific evidence from a systematic review of medical literature, and on a consensus of expert opinion when scientific evidence was insufficient or inconclusive. Visit the department’s Medical Treatment Guidelines webpage for detailed information on the guideline development process. c A. Background and Prevalence Workplace accidents (...) and Industries Surgical Guideline for Work-related Ankle and Foot Injuries – October 2017 I. Review Criteria for Foot and Ankle Surgery Note: Not all surgical procedures that require prior authorization appear in this criteria table. A request may be appropriate for If the patient has AND the diagnosis is supported by these clinical findings: AND this has been done Surgical Procedure Condition or Diagnosis Subjective Objective Imaging Non-operative care Ankle Arthroscopy Loose body A discrete documented work

2017 Washington State Department of Labor and Industries

160. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

Angiography and Interventions Representative. ¶ACC/AHA Task Force on Clinical Practice Guidelines Liaison. #Inter-Society Consensus for the Management of Peripheral Arterial Disease Representative. **Society for Vascular Medicine Representative. ††Society of Interventional Radiology Representative. ‡‡Society for Clinical Vascular Surgery Representative. §§Society for Vascular Surgery Representative. ? ?American Association of Cardiovascular and Pulmonary Rehabilitation Representative. ¶¶Society (...) College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726–e779. DOI: 10.1161/CIR.0000000000000471. Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation, Inter-Society Consensus for the Management of Peripheral Arterial Disease, Society for Cardiovascular Angiography and Interventions, Society for Clinical Vascular Surgery, Society of Interventional Radiology, Society for Vascular Medicine

2017 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>